State Street Corp Singular Genomics Systems, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.37 - $0.99 $9,990 - $26,730	-27,000 Reduced 19.34%	112,615 $42,000
Q2 2023 Aug 14, 2023	SELL	$0.78 - $1.28 $584,431 - $959,066	-749,271 Reduced 84.29%	139,615 $115,000
Q1 2023 May 15, 2023	BUY	$1.1 - $2.95 $793 - $2,126	721 Added 0.08%	888,886 $1.08 Million
Q4 2022 Feb 14, 2023	BUY	$1.82 - $2.71 $140,413 - $209,076	77,150 Added 9.51%	888,165 $1.79 Million
Q3 2022 Nov 15, 2022	BUY	$2.5 - $4.73 $168,637 - $319,062	67,455 Added 9.07%	811,015 $2.03 Million
Q2 2022 Aug 15, 2022	BUY	$2.86 - $6.44 $653,541 - $1.47 Million	228,511 Added 44.37%	743,560 $2.84 Million
Q1 2022 May 16, 2022	BUY	$5.94 - $12.09 $1.9 Million - $3.87 Million	319,753 Added 163.73%	515,049 $3.25 Million
Q4 2021 Feb 14, 2022	BUY	$10.45 - $16.9 $834,651 - $1.35 Million	79,871 Added 69.2%	195,296 $2.26 Million
Q3 2021 Nov 15, 2021	BUY	$10.9 - $27.63 $1.26 Million - $3.19 Million	115,425 New	115,425 $1.29 Million

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.4B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.